Glaxosmithkline Share News (GSK)
GSK Share
GSK Share
GSK Share
GSK Share
GSK
GSK Share
GSK Level 2
GSK Live
GSK Broker
GSK Directors
GSK Financial
GSK
GSK Short
GSK
Last checked at -
* Marketing head says will focus on established categories* Says growth profile will support higher debt burden* GSK sees lasting consumer taste for preventative products* Rogers speaks at Reuters Marketing Interactive WeekBy Ludwig BurgerJune 9 (Reu...
Read more(adds withdrawal of U.S. restrictions, paragraph 11; and statistic on vaccinations in last line)By Robin Emmott and Francesco GuarascioBRUSSELS, June 9 (Reuters) - The European Union and the United States are set to agree at a summit on Tuesday to ...
Read more
GSK encourages ADS holders to reject TRC Capital "mini-tender" offer
Read more(Refiles to change word in headline)By Jeff Mason and Carl O'DonnellWASHINGTON, June 3 (Reuters) - The White House laid out a plan for the United States to share 25 million surplus COVID-19 vaccine doses to the world, with the first shots shipping ...
Read more(Adds plan details, national security adviser, IMF comment, Public Citizen reaction)By Jeff Mason and Carl O'DonnellWASHINGTON, June 3 (Reuters) - The White House on Thursday laid out a plan for the United States to share 25 million surplus COVID-...
Read more(Adds reaction, background)By Jeff Mason and Carl O'DonnellWASHINGTON, June 3 (Reuters) - The White House laid out a plan on Thursday for the United States to share 25 million surplus COVID-19 vaccine doses with the world and said it would lift so...
Read more(Adds comment from US-ASEAN business council)By Jeff Mason and Carl O'DonnellWASHINGTON, June 3 (Reuters) - The White House laid out a plan for the United States to share 25 million surplus COVID-19 vaccine doses to the world, with the first shots ...
Read moreDUBAI, June 2 (Reuters) - Kuwait has approved GSK and Vir Biotechnology's Sotrovimab as a treatment for coronavirus, state news KUNA reported on Wednesday.Kuwait is the second country in the Middle East to approve the use of the antibody treatment...
Read moreBy Nancy LapidMay 28 (Reuters) - The following is a roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus.India variant shows resistance ...
Read more
(Sharecast News) - Activist investor Elliott Management will not call for GlaxoSmithKline to sell its vaccines and pharmaceuticals business after taking a big stake in the FTSE 100 drugs company, The Times reported.
Read more(Sharecast News) - GlaxoSmithKline announced on Wednesday that 'sotrovimab' has received emergency use approval in the United States for the treatment of Covid-19, while it also started a global phase 3 study of its Covid-19 vaccine candidate with Sanofi.
Read more(Adds details, quote)By Dominique VidalonPARIS, May 27 (Reuters) - France's Sanofi and Britain's GlaxoSmithKline launched a late-stage human trial for a recombinant COVID-19 vaccine candidate on Thursday which they hope to get approved by the end ...
Read moreTOP NEWS: GSK and Sanofi launch phase three study for Covid vaccine
Read morePARIS, May 27 (Reuters) - Sanofi and GlaxoSmithKline said on Thursday they were launching Phase III trial, the late-stage before submitting approval, for their experimental COVID-19 vaccine.Pending positive phase III outcome, the vaccine could be ...
Read moreUS regulator authorises GSK and Vir's sotrovimab for Covid treatment
Read more
Last checked at